13,479 followers
586 followers
@APassaroMD @JackWestMD @n8pennell @DrSanjayPopat @VivekSubbiah @Alfdoc2 @drgandara @Tony_Calles @Jbauml @NarjustDumaMD DFS is a valid surrogate for OS whenever there is no meaningful clinical benefit from a 2nd line therapy (i.e. short post-progression su
163 followers
RT @JohnTuckerPhD: Interesting paper on the PFS-as-endpoint issue. For 280 pt trial with 3 mo improvement in both PFS & OS: 90% chance o…
8 followers
RT @JohnTuckerPhD: Interesting paper on the PFS-as-endpoint issue. For 280 pt trial with 3 mo improvement in both PFS & OS: 90% chance o…